A Case of Nitroimidazole-Resistant Trichomonas vaginalis in a 30-Year-Old Female With an Intrauterine Device

Workowski, 2021, Sexually transmitted infections treatment guidelines, 2021, MMWR Recomm Rep, 70 Flagg EW, Meites E, Phillips C, Papp J, Torrone EA. Prevalence of Trichomonas vaginalis among males and females aged 14–59 years. Sex Transm Dis. Published online May 2019. https://doi.org/10.1097/olq.0000000000001013 Lewis FMT, Spicknall IH, Flagg EW, Papp JR, Kreisel KM. Incidence and prevalence of Trichomonas vaginalis infection among persons aged 15–59: United States, 2018. Sexually Transmitted Diseases. Published online January 23, 2021. https://doi.org/10.1097/OLQ.0000000000001383 Chellan, 2019, Antiprotozoal activity of palladium(II) salicylaldiminato thiosemicarbazone complexes on metronidazole resistant Trichomonas vaginalis, Inorg Chem Commun, 102, 1, 10.1016/j.inoche.2019.01.033 Van Gerwen, 2019, Recent advances in the epidemiology, diagnosis, and management of Trichomonas vaginalis infection, F1000Research, 8, 1666, 10.12688/f1000research.19972.1 Van Der Pol, 2021, Trichomonas vaginalis detection in urogenital specimens from symptomatic and asymptomatic men and women by use of the cobas TV/MG Test, J Clin Microbiol, 59, 10.1128/JCM.00264-21 Danby, 2021, Nucleic acid amplification testing compared with cultures, Gram stain, and microscopy in the diagnosis of vaginitis.”, J Lower Genital Tract Dis, 25, 76, 10.1097/LGT.0000000000000576 Kissinger, 2022, Diagnosis and management of Trichomonas vaginalis: summary of evidence reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines, Clin Infect Dis, 74, S152, 10.1093/cid/ciac030 Alessio, 2019, Management of resistant trichomoniasis, Curr Infect Dis Rep, 21, 31, 10.1007/s11908-019-0687-4 Kingston, 2003, “Shelf life” of Trichomonas vaginalis, Int J STD AIDS, 14, 28, 10.1258/095646203321043228 Schwebke, 2018, Clinical evaluation of the Cepheid Xpert TV assay for detection of Trichomonas vaginalis with prospectively collected specimens from men and women, J Clin Microbiol, 56, 10.1128/JCM.01091-17 Craig-Kuhn, 2019, Optimal timing for Trichomonas vaginalis test of cure using nucleic acid amplification testing, Sex Transm Dis, 46, 312, 10.1097/OLQ.0000000000000968 Howe, 2017, Single-dose compared with multidose metronidazole for the treatment of trichomoniasis in women, Sex Transm Dis, 44, 30, 10.1097/OLQ.0000000000000537 Wood, 1975, Pharmacokinetics of tinidazole and metronidazole in women after single large oral doses, Sex Transm Infect, 51, 51, 10.1136/sti.51.1.51 Ghosh, 2018, In vitro study of the susceptibility of clinical isolates of trichomonas vaginalis to metronidazole and secnidazole, Antimicrob Agents Chemother, 62, 10.1128/AAC.02329-17 Bosserman, 2011, Utility of antimicrobial susceptibility testing in Trichomonas vaginalis–infected women with clinical treatment failure, Sex Transm Dis, 38, 983, 10.1097/OLQ.0b013e318224db39